Novartis to Initiate Recall of OTC Drugs Excedrin and Bufferin

by Kathy Jones on  January 9, 2012 at 8:47 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Following complaints over mislabeling and broken pills, Novartis revealed that it will be recalling a number of its over-the-counter drugs including bottles of Excedrin and Bufferin.
 Novartis to Initiate Recall of OTC Drugs Excedrin and Bufferin
Novartis to Initiate Recall of OTC Drugs Excedrin and Bufferin

The pharmaceutical giant released a statement which said that it will be recalling "Excedrin and NoDoz products with expiration dates of December 20, 2014, or earlier, as well as Bufferin and Gas-X Prevention products with December 20, 2013, or earlier expiration dates."

The statement added that the company will be shutting down Novartis Consumer Health (NCH) Lincoln, Nebraska facility on a temporary basis in order to accelerate maintenance at the site. The recalls and the upgrade of the facility is expected to cost Novartis around $120 million in the fourth quarter.

Novartis was keen to stress that the recalls were voluntary and precautionary and there have not been any adverse effects reported. "Novartis s taking this action as a precautionary measure, because the products may contain stray tablets, capsules or caplets from other Novartis products, or contain broken or chipped pills", the statement said.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Drugs Banned in India Choose The Right Over-the-Counter Drugs for Allergy Drug Overdose 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...